How Does Automation of Datasets Preparation Save Time and Reduce Risk in Rational Drug Discovery?
Although the amount of biomolecular structural data is exponentially increasing, the generation of knowledge based on this data is not growing nearly as fast.
One weakness is still present traditional processes (e.g. manual analysis of datasets) and legacy applications within pharma units that cannot deal with big protein structure data efficiently.
Example of biomolecular data expansion - increase of PDB structures released per year https://www.rcsb.org/stats/growth/growth-released-structures
For example, the same amount of knowledge that was generated in 5 minutes in the past might now take 2-3 business days due to large datasets. This leaves teams with more time on low-value tasks and less time for actual discovery.
Moreover, manual work carries out risks of human error, which can result in wrong reasoning, false knowledge, bad decisions and ultimately a failure.
Focus On Ideation Not On Data Management
To spend 5 minutes translating even big data coming from protein structures to knowledge, the first step is to automate data processing and analysis with modern technologies. They will allow your team to focus on innovation, not on data management, and perform quickly the next business decision.
3decision is a modern software solution with state-of-the-art technology that streamlines the complex 3D protein data registration, curation and routine analysis to allow scientists to quickly solve problems relying on a structure-based drug discovery approach and progress twice as fast.
Automation of 3D Data Management and Analysis in 3decision Allows You To:
Reduce low-value activities and generate knowledge with automated data analysis to speed up data-driven decision making
Foster AI/ML analysis with automatically prepared datasets (in less than 2 minutes)
Avoid unnecessary costs by reducing risks of making manual mistakes
The empowerment of data-driven decision making in pharma R&D to speed up the development of next-generation drugs is our mission at Discngine! During 15 years of experience, Discngine has developed effective digital solutions to streamline the early drug design processes and accelerate drug discovery.
Our Mission
Discngine is a Winner of 2019 Bio-IT World Innovative Practices Awards together with Abbvie for the co-development of 3decision®
“We were sitting on these almost 9,000 structures, and except for 2-3 people, nobody else knew where they were.”
- Rishi Gupta, Senior Research Scientist at Abbvie
“The 3decision® site has become a key stopping point for our scientists who design compounds, analyze and share protein structures, and retrieve external and internal protein x-ray and NMR structures.”
- Research Fellow, Discovery Chemistry at Abbvie
